Concepedia

Gilbert C. Olini

GC

Statistics

Publications

8

Citations

661

H-Index

8

Active since

1985

Affiliations

Johnson & Johnson (United States)(Current)

Gilbert C. Olini is an author at Johnson & Johnson (United States) specializing in pharmacology, life sciences, and molecular pharmacology.

Publications per year

1985–2014

8

Publications

8

Imidazopyrimidines, potent inhibitors of p38 MAP kinase

Kenneth C. Rupert, James R. Henry, John H. Dodd et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 252 citations · Full text

, , +9

RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase

Scott Wadsworth, Druie Cavender, Scott A. Beers et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 158 citations

, , +17

6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (RWJ 68354):  A Potent and Selective p38 Kinase Inhibitor

James R. Henry, Kenneth C. Rupert, John H. Dodd et al. · Journal of Medicinal Chemistry · 1998 · 77 citations · Full text

, , +5

Activated human B cells display a functional IL 2 receptor.

Robert S. Mittler, Patricia E. Rao, Gilbert C. Olini et al. · The Journal of Immunology · 1985 · 73 citations · Full text

, , +9

Purine derivatives as potent Bruton’s tyrosine kinase (BTK) inhibitors for autoimmune diseases

Qing Shi, Andrew J. Tebben, Alaric J. Dyckman et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 39 citations · Full text

, , +15

1–5 of 8